ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,683Medicare Part D Prescriptions Filled, Including Refills

Rank: 233 out of 2604

$398K Total Retail Price of All Prescriptions

Rank: 385 out of 2604

294 Patients Receiving at Least One Drug in Part D
27%Patients 65 Years and Older
93% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

14% of this provider’s 294 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

3% of this provider’s 2,081 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
LISINOPRIL 389 132 1 3
METFORMIN HCL 300 72 2 7
OMEPRAZOLE 252 55 3 5
SIMVASTATIN 242 110 4 2
HYDROCODONE-ACETAMINOPHEN 235 63 S3 5 1
ATENOLOL 180 78 6 11
LEVOTHYROXINE SODIUM 176 59 7 4
PROAIR HFA 175 21 8 27
PRAVASTATIN SODIUM 170 86 9 14
SPIRIVA 169 30 10 45
AMLODIPINE BESYLATE 158 63 11 6
HYDROCHLOROTHIAZIDE 150 81 12 10
TRAMADOL HCL 147 51 13 15
CITALOPRAM HBR 140 26 14 18
GEMFIBROZIL 134 0 15 87
FUROSEMIDE 112 21 16 8
GABAPENTIN 108 18 17 12
RANITIDINE HCL 100 17 18 25
METOPROLOL TARTRATE 92 38 19 9
LISINOPRIL-HYDROCHLOROTHIAZIDE 92 40 19 22
GLIPIZIDE 90 23 21 51
POTASSIUM CHLORIDE 90 25 21 16
CYCLOBENZAPRINE HCL 87 0 R 23 43
IBUPROFEN 85 35 24 32
AMITRIPTYLINE HCL 85 26 R 24 82
FAMOTIDINE 83 17 26 68
WARFARIN SODIUM 79 19 27 13
FLUOXETINE HCL 71 0 28 49
NEXIUM 69 17 29 53
MELOXICAM 69 17 29 36
ADVAIR DISKUS 66 11 31 41
NAPROXEN 66 0 31 76
VENLAFAXINE HCL ER 66 46 31 107
TRIAMTERENE-HCTZ 66 12 31 55
VENTOLIN HFA 63 11 35 63
CHLORZOXAZONE 61 0 R 36 378
SYMBICORT 61 0 36 105
PHENYTOIN SODIUM EXTENDED 59 12 38 135
CYMBALTA 58 0 39 44
TRAZODONE HCL 58 0 39 46
ZOLPIDEM TARTRATE 56 0 41 21
METOPROLOL SUCCINATE 55 24 42 17
FENOFIBRATE 54 0 43 69
GLYBURIDE 53 12 R 44 83
ENALAPRIL MALEATE 53 12 44 50
SINGULAIR 53 11 44 120
SERTRALINE HCL 50 28 47 23
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.